The chemical substance with the name "NA" and CAS number 2661053-09-2 is not widely recognized in standard chemical databases or literature, suggesting it may be a specialized compound or a less common substance. Typically, the abbreviation "NA" could refer to sodium (Na), but in this context, it likely represents a specific compound or formulation. Characteristics of a chemical substance generally include its molecular formula, physical state (solid, liquid, gas), melting and boiling points, solubility in various solvents, reactivity with other chemicals, and potential applications. Additionally, safety data such as toxicity, handling precautions, and environmental impact are crucial for understanding its use. For precise information, including its structure and properties, consulting specialized chemical databases or scientific literature would be necessary. If you have access to specific resources or databases, they may provide detailed insights into this particular substance.

2661053-09-2: The chemical substance with the name "NA" and CAS number 2661053-09-2 is not widely recognized in standard chemical databases or literature, suggesting it may be a specialized compound or a less common substance. Typically, the abbreviation "NA" could refer to sodium (Na), but in this context, it likely represents a specific compound or formulation. Characteristics of a chemical substance generally include its molecular formula, physical state (solid, liquid, gas), melting and boiling points, solubility in various solvents, reactivity with other chemicals, and potential applications. Additionally, safety data such as toxicity, handling precautions, and environmental impact are crucial for understanding its use. For precise information, including its structure and properties, consulting specialized chemical databases or scientific literature would be necessary. If you have access to specific resources or databases, they may provide detailed insights into this particular substance.

<p>KYLO-0603 is an orally active and selective THR-β agonist with an EC50 of 31.07 nM. It effectively reduces serum cholesterol and low-density lipoprotein cholesterol levels. By activating THR-β receptors, KYLO-0603 enhances the expression of THR-regulated genes like iodothyronine deiodinase 1 (Dio1), malic enzyme 1 (Me1), and thyroid hormone-responsive (Thrsp) gene, while it inhibits the expression of inflammatory and fibrosis-related genes, including low-density lipoprotein receptor (LDL-R) gene. This compound is applicable for the study of metabolic associated steatohepatitis (MASH) and liver fibrosis.</p>

CAS 2661053-09-2

NA

Kylo-0603

Ref: TM-T207023